At-Home Drug of Abuse (DOA) Testing Market

At-Home Drug of Abuse (DOA) Testing Market

Market Size and Forecast:

The At-Home Drug of Abuse (DOA) Testing Market Size reached US$ 2.62 Billion in 2024 and is expected to reach US$ 5.09 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.

The At-Home Drug of Abuse (DOA) Testing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/at-home-drug-of-abuse-testing-market?sz

The At-Home Drug of Abuse Testing Market encompasses the development, production, and sale of diagnostic kits that allow individuals to screen for drug use in the comfort and privacy of their homes. These tests detect substances such as opioids, cannabis, and amphetamines, offering rapid, convenient, and confidential results, supporting personal health monitoring, workplace safety, and early intervention in substance abuse.

Industry Recent Developments:

United States:

✅ September 2025: The US market for drug abuse testing is projected to grow significantly, driven by rising substance misuse, stringent workplace regulations, technological advancements in testing methods (urine, saliva, hair, blood), government support, and rising public awareness.

✅ October 2025: The market is expected to experience strong growth with a CAGR of around 8.6% over 2025-2032, with an increasing focus on digital integration with testing kits, privacy and confidentiality, and growth of online retail platforms for easy access to at-home drug test kits.

✅ August 2025: There is increasing adoption of rapid, user-friendly, and non-invasive testing solutions such as saliva-based tests and multiplex panels, expanding the application areas from personal monitoring to workplace wellness programs.

Japan:

✅ October 2025: The Japan drugs of abuse testing market size is about USD 149.76 million in 2025, with recent developments pointing to management changes and SWOT analysis reflecting market adjustments.

✅ September 2025: Japan shows a CAGR of approximately 14.3% projected in the drug screening market for 2025-2033, indicating rapid market expansion fueled by growing awareness, healthcare infrastructure improvements, and increasing preventive healthcare measures.

✅ August 2025: Japan’s DOA testing market is projected to grow significantly by 2033, with increasing investments in drug abuse testing technologies and applications in workplaces and healthcare settings, reflecting an expanding demand for at-home and point-of-care testing solutions.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/at-home-drug-of-abuse-testing-market?sz

Major Key Players:

Abbott Laboratories

OraSure Technologies, Inc

Psychemedics Corporation

NMS Labs

Premier Biotech

First Check Diagnostics

Atlas Medical

Cliawaived, Inc

Frenovo Biotech.

Key Growth Drivers:

Increasing Awareness and Importance of Early Detection: Growing public awareness about drug abuse and the critical need for early detection promote adoption of at-home testing solutions. More individuals seek convenient, private, and reliable options for monitoring substance use without stigma or confidentiality concerns.

Technological Advancements: Innovations in testing technologies have improved accuracy, sensitivity, and ease of use in at-home DOA kits. Integration with digital platforms and mobile apps enhances user experience with guided instructions and result tracking, boosting consumer confidence.

Rise in Substance Abuse Prevalence and Privacy Demand: The global rise in substance abuse disorders drives demand for accessible and discreet testing methods. At-home kits offer privacy and convenience, appealing to individuals, families, employers, and healthcare settings that require frequent testing or monitoring.

Segments Covered in the At-Home Drug of Abuse (DOA) Testing Market:

By Product: Urine Drug Test Kits, Oral Fluid Drug Test Kits, Hair Drug Test Kits, Saliva Drug Test Kits, Others.

By Drug Type: Marijuana (THC), Amphetamines, Opiates, Benzodiazepines, Methamphetamines, Others.

By End User: Hospitals, Diagnostic Centers, Clinical Laboratories, Homecare Settings.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=at-home-drug-of-abuse-testing-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, At-Home Drug of Abuse (DOA) Testing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global At-Home Drug of Abuse (DOA) Testing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global At-Home Drug of Abuse (DOA) Testing market’s leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the At-Home Drug of Abuse (DOA) Testing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the At-Home Drug of Abuse (DOA) Testing Market in 2025?

◆ What is the projected growth rate of the At-Home Drug of Abuse (DOA) Testing Market through 2033?

◆ Who are the key players in the At-Home Drug of Abuse (DOA) Testing Market?

◆ Which region is expected to dominate the industry during the forecast period?

Contact Us –

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us –

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.